XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 13 - Segment Information
9 Months Ended
Oct. 01, 2022
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

13.  Segment Information

 

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers.  The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended January 1, 2022).

 

Segment operating income (loss) includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

 

Thirteen Weeks Ended

October 1, 2022

 

Engineering

  

Specialty

Health Care

  

Information

Technology

  

Corporate

  

Total

 

Revenue

 $20,922  $27,997  $9,233  $-  $58,152 

Cost of services

  15,594   19,014   6,186   -   40,794 

Gross profit

  5,328   8,983   3,047   -   17,358 

Selling, general and administrative

  4,531   5,933   2,087   -   12,551 

Depreciation and amortization of

property and equipment

  136   101   29   -   266 

Gain on sale of assets

  (219

)

  -   -   -   (219

)

Operating income

 $880  $2,949  $931  $-   4,760 

Total assets as of October 1, 2022

 $32,343  $33,280  $8,579  $2,607  $76,809 

Capital expenditures

 $207  $9  $39  $266  $521 

 

 

Thirteen Weeks Ended

October 2, 2021

 

Engineering

  

Specialty

Health Care

  

Information

Technology

  

Corporate

  

Total

 

Revenue

 $16,482  $19,646  $9,343  $-  $45,471 

Cost of services

  12,694   14,115   6,448   -   33,257 

Gross profit

  3,788   5,531   2,895   -   12,214 

Selling, general and administrative

  3,834   4,415   2,133   -   10,382 

Depreciation and amortization of

property and equipment

  120   99   31   -   250 

Amortization of acquired intangible

assets

  6   -   -   -   6 

Gain on sale of assets

  (2,151

)

  -   -   -   (2,151

)

Operating income

 $1,979  $1,017  $731  $-  $3,727 

Total assets as of October 2, 2021

 $29,020  $26,483  $8,560  $6,228  $70,291 

Capital expenditures

 $16  $168  $35  $139  $358 

 

 

 

Thirty-Nine Weeks Ended

October 1, 2022

 

Engineering

  

Specialty

Health Care

  

Information

Technology

  

Corporate

  

Total

 

Revenue

 $61,726  $123,638  $29,095  $-  $214,459 

Cost of services

  45,653   86,772   19,573   -   151,998 

Gross profit

  16,073   36,866   9,522   -   62,461 

Selling, general and administrative

  12,659   21,203   6,100   -   39,962 

Depreciation and amortization of

property and equipment

  332   322   75   -   729 

Gain on sale of assets

  (219

)

  -   -   -   (219

)

Operating income

 $3,301  $15,341  $3,347  $-  $21,989 

Total assets as of October 1, 2022

 $32,343  $33,280  $8,579  $2,607  $76,809 

Capital expenditures

 $496  $57  $102  $275  $930 

 

 

Thirty-Nine Weeks Ended

October 2, 2021

 

Engineering

  

Specialty

Health Care

  

Information

Technology

  

Corporate

  

Total

 

Revenue

 $47,882  $63,723  $27,348  $-  $138,953 

Cost of services

  36,875   47,564   19,184   -   103,623 

Gross profit

  11,007   16,159   8,164   -   35,330 

Selling, general and administrative

  10,570   12,937   6,059   -   29,566 

Depreciation and amortization of

property and equipment

  428   260   87   -   775 

Amortization of acquired intangible

assets

  95   -   -   -   95 

Gain on sale of assets

  (2,151

)

  -   -   -   (2,151

)

Operating income

 $2,065  $2,962  $2,018  $-  $7,045 

Total assets as of October 2, 2021

 $29,020  $26,483  $8,560  $6,228  $70,291 

Capital expenditures

 $55  $235  $44  $165  $499 

 

 

 

The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers.  The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the thirteen and thirty-nine weeks ended October 1, 2022 and October 2, 2021 was as follows: 

 

  

Thirteen Weeks Ended

  

Thirty-Nine Weeks Ended

 
  

October 1,

2022

  

October 2,

2021

  

October 1,

2022

  

October 2,

2021

 

Revenue

                

U. S.

 $55,180  $41,584  $205,162  $124,337 

Canada

  1,091   1,912   3,555   8,371 

Puerto Rico

  1,261   1,245   3,760   4,128 

Serbia

  620   730   1,982   2,117 
  $58,152  $45,471  $214,459  $138,953 

 

Total assets by geographic area as of the reported periods were as follows:

 

  

October 1,

2022

  

January 1,

2022

 

Total assets

        

U. S.

 $73,700  $69,566 

Canada

  959   1,327 

Puerto Rico

  1,351   963 

Serbia

  799   996 
  $76,809  $72,852